Successful cardiac resynchronization therapy in a 3-year-old girl with isolated left ventricular non-compaction and

Kazuyoshi Saito1, Keijirou Ibuki, Naoki Yoshimura

  • 1Department of Pediatrics, University of Toyama, Toyama, Japan.

Insights

Cardiac resynchronization therapy (CRT) improved heart failure in a child with left ventricular non-compaction (LVNC). This pediatric CRT treatment was effective even with a narrow QRS complex, suggesting improved long-term outcomes.

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Engineering
  • Heart Failure Management

Background:

  • Cardiac resynchronization therapy (CRT) is established for adult heart failure, but its use in children, particularly those with left ventricular non-compaction (LVNC), is not well-defined.
  • Indications, efficacy, and long-term prognosis of pediatric CRT remain areas of active investigation.

Observation:

  • A 3-year-old girl with intractable heart failure due to isolated LVNC and a narrow QRS complex presented with severe left ventricular dysfunction (ejection fraction 29.3%) and mitral regurgitation.
  • Echocardiography revealed diffuse hypokinesis and significant dyssynchrony in LV wall motion, characterized by prominent trabeculations.

Findings:

  • Biventricular resynchronization via epicardial pacing was successfully performed, with optimal pacing sites identified using tissue Doppler imaging and AV delay optimized for maximal hemodynamic benefit.
  • Over a 2-year follow-up, the patient demonstrated substantial and sustained improvements in LV function and clinical status, with a significant decrease in BNP levels (1,960 to 82 pg/ml).
  • Notably, QRS duration remained unchanged (103 ms) post-CRT, indicating efficacy beyond traditional QRS widening criteria.

Implications:

  • Pediatric CRT can be a valuable therapeutic option for refractory heart failure in children, including those with LVNC and narrow QRS complexes.
  • This case suggests that CRT may improve the prognosis for pediatric patients with LVNC, challenging previous assumptions about QRS duration requirements.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...